Contributor Page
Norton Rose Fulbright Canada LLP
Email  |  Website  |  Articles
Contact Details
Tel: +1 416 2164000
Fax: +1 416 2163930
Suite 3800
Royal Bank Plaza, South Tower
200 Bay Street, P.O. Box 84
Ontario M5J 2Z4
Contributor Most Read
By Graeme Austin
On May 17, Bill 24 "Business Corporations Amendment Act, 2019" (the Amendment Act) received royal assent in the British Columbia legislature.
By Lorelei Graham
Canada will now follow the international classification system under the Nice Treaty currently adopted in Europe and the United States.
By Lorelei Graham
The new rules will allow for immediate registration of a trademark once it has completed the advertisement period.
By Sara Zborovski, Lorelei Graham
Keep in mind any cannabis branding strategy or selection should always march in step with the strict regulatory framework relating to advertising, packaging and labeling.
By Simon Lovegrove
On 24 April 2019, the FCA published its approach to supervision (the Approach) following on from the FCA's March 2018 consultation paper on the same topic
By Kathy L. Krug
Explore the article for practical solutions for avoiding these antitrust issues.
By Troy Ungerman
On the market side, private cannabis companies are driving up cannabis M&A activities.
By Jean-François Drolet
Cet épisode est axé sur les changements apportés à la Loi sur les marques de commerce qui permettront au Canada d'adhérer au Protocole de Madrid et à la Classification de Nice.
By Karen MacDonald
This episode focuses on the amendments to Canada's Trade-marks Act that will allow the country to accede to the Madrid Protocol and Nice Agreement.
By Sara Zborovski
On May 8, Health Canada announced that, effective immediately, all new applicants for a licence to cultivate, process, or sell cannabis for medical purposes are required to have a fully built site that meets...
By Marie-Helene Rochon
Notre groupe organise une conférence bien spéciale le 22 mai prochain sur les conséquences de l'intersection entre la santé et l'intelligence artificielle
By Dominic Dupoy
This doctrine is an important defense available to prescription drug manufacturers to establish they have met their duty to warn.
By Nader Hasan
Entrepreneurs don't start businesses for the thrill of good record keeping, developing and maintaining a comprehensive capitalization table and keeping up to speed on corporate governance best practices.
By Janet Bobechko
On April 18, Ontario's Ministry of the Environment, Conservation and Parks announced a proposal to amend the Endangered Species Act, 2007, SO 2007, c 6 (the Act).
By Carl Deeprose
ITA regulation 102 requires employers to withhold tax on remuneration paid to non-resident employees who are employed in Canada.
Contributor's Topics